chr17-77281529-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001113491.2(SEPTIN9):c.-7A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0929 in 1,548,048 control chromosomes in the GnomAD database, including 9,435 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 2799 hom., cov: 33)
Exomes 𝑓: 0.087 ( 6636 hom. )
Consequence
SEPTIN9
NM_001113491.2 5_prime_UTR
NM_001113491.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.353
Genes affected
SEPTIN9 (HGNC:7323): (septin 9) This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 17-77281529-A-C is Benign according to our data. Variant chr17-77281529-A-C is described in ClinVar as [Benign]. Clinvar id is 1239714.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-77281529-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.334 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEPTIN9 | NM_001113491.2 | c.-7A>C | 5_prime_UTR_variant | 1/12 | ENST00000427177.6 | NP_001106963.1 | ||
SEPTIN9 | NM_001293695.2 | c.-7A>C | 5_prime_UTR_variant | 1/11 | NP_001280624.1 | |||
SEPTIN9-DT | NR_136503.1 | n.286+83T>G | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.151 AC: 22901AN: 151948Hom.: 2790 Cov.: 33
GnomAD3 genomes
AF:
AC:
22901
AN:
151948
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0871 AC: 12898AN: 148096Hom.: 852 AF XY: 0.0887 AC XY: 7092AN XY: 79990
GnomAD3 exomes
AF:
AC:
12898
AN:
148096
Hom.:
AF XY:
AC XY:
7092
AN XY:
79990
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0866 AC: 120909AN: 1395986Hom.: 6636 Cov.: 31 AF XY: 0.0869 AC XY: 59856AN XY: 688908
GnomAD4 exome
AF:
AC:
120909
AN:
1395986
Hom.:
Cov.:
31
AF XY:
AC XY:
59856
AN XY:
688908
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.151 AC: 22946AN: 152062Hom.: 2799 Cov.: 33 AF XY: 0.148 AC XY: 10992AN XY: 74368
GnomAD4 genome
AF:
AC:
22946
AN:
152062
Hom.:
Cov.:
33
AF XY:
AC XY:
10992
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
397
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 06, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
SEPTIN9-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at